ALLO
Allogene Therapeutics, Inc. · Healthcare
Director Stephen Mayo sold $43K of Allogene Therapeutics, Inc.
Sold$42,855
$4.29Price
10,000Shares
−28%Stake
What ALLO did after the filing
- The stock from Wed, Aug 9 close, $4.34
- −14.3%
- S&P 500, same days
- −2.9%
Measured over 30 trading days, to the Sep 21 close.
Traded Mon, Aug 7. Filed Wed, Aug 9, 12:07 PM ET, during the session. Returns use the Aug 9 close and the Sep 21 close. Not investment advice.